(Q50910087)

25 March 2018

title

Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension (English)

1 reference

25 March 2018

2

Schunkert H

1 reference

25 March 2018

Muscholl MW

1

1 reference

25 March 2018

Muders F

3

1 reference

25 March 2018

Elsner D

4

1 reference

25 March 2018

Kuch B

5

1 reference

25 March 2018

Hense HW

6

1 reference

25 March 2018

Riegger GA

7

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

25 March 2018

published in

American Heart Journal

1 reference

25 March 2018

volume

135

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

58-66

1 reference

25 March 2018

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Left ventricular hypertrophy: effect on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Left ventricular mass and subsequent blood pressure changes among middle-aged men in rural and urban Japanese populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Prognosis of left ventricular geometric patterns in the Framingham heart study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Angiotensin II–Induced Growth Responses in Isolated Adult Rat Hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Molecular basis of human hypertension: role of angiotensinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Left ventricular radius to wall thickness ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomic validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Angiotensin II: hemodynamic regulator or growth factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Renal haemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ACE inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Dietary salt intake. A determinant of cardiac involvement in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Release of atrial natriuretic peptide by atrial distension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

High levels of plasma atrial natriuretic factor and impaired left ventricular diastolic function in hypertensives without left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Atrial natriuretic factor in essential hypertension: echocardiographic and humoral correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

Correlation between cardiac hypertrophy and plasma levels of atrial natriuretic factor in non-spontaneous models of hypertension in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970343-6

10.1016/S0002-8703(98)70343-6

7 January 2021

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018